Effects of Asprosin and Role of TLR4 as a Biomarker in Endometrial Cancer
Molecules · 2025
DOI: 10.3390/molecules30163410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Rebecca Karkia und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Health, Medicine and Life Sciences, Brunel University of London, Uxbridge UB8 3PH, UK. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Toll-Like Receptor 4, Biomarkers, Tumor, Fibrillin-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GRACE charity and UHCW, Gynae-oncology Research and Clinical Excellence (GRACE) charity, University Hospital Coventry & Warwickshire (UHCW).
Abstract (Originalsprache)
(1)
Background
Following the discovery of the adipokine/hormone asprosin, a substantial amount of research has provided evidence for its role in the regulation of glucose homeostasis, as well as appetite, and insulin sensitivity. Its levels are dysregulated in certain disease states, including breast cancer. To date, little is known about its role in endometrial cancer (EC). The present study investigated the effects of asprosin on the transcriptome of the Ishikawa and NOU-1 EC cell lines, and assessed the expression of asprosin’s candidate receptors (TLR4, PTPRD, and OR4M1) in health and disease. (2) Methods: tissue culture, RNA extraction, RNA sequencing, reverse transcription-quantitative PCR, gene enrichment and in silico analyses were used for this study. (3)
Results
TLR4 and PTPRD were significantly downregulated in EC when compared to healthy controls. TLR4 appeared to have a prognostic role in terms of overall survival (OS) in EC patients (i.e., higher expression, better OS). RNA sequencing revealed that asprosin affected 289 differentially expressed genes (DEGs) in Ishikawa cells and 307 DEGs in NOU-1 cells. Pathway enrichment included apoptosis, glycolysis, hypoxia, and PI3K/AKT/ mTOR/NOTCH signalling for Ishikawa-treated cells. In NOU-1, enriched processes included inflammatory response, epithelial-mesenchymal transition, reactive oxygen species pathways, and interferon gamma responses. Other signalling pathways included mTORC1, DNA repair, and p53, amongst others. (4)
Conclusions
These findings underscore the importance of understanding receptor dynamics and signalling pathways in the context of asprosin’s role in EC, and provide evidence for a potential role of TLR4 as a diagnostic biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Health, Medicine and Life Sciences, Brunel University of London, Uxbridge UB8 3PH, UK.
- Academic Department of Gynaecological Oncology, Royal Surrey NHS Foundation Trust Hospital, Guildford GU2 7XX, UK.
- Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK.
- Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham B4 7ET, UK.
- Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.
- Centre for Sport, Exercise and Life Sciences, Research Institute for Health and Wellbeing, Coventry University, Coventry CV1 5FB, UK.
ORCID-Profile: Rebecca Karkia, Cristina Sisu, Ioannis Kyrou, Jayanta Chatterjee
Förderung
- GRACE charity and UHCW
- Gynae-oncology Research and Clinical Excellence (GRACE) charity
- University Hospital Coventry & Warwickshire (UHCW)
- NHS Trust
Zitieren
APA
Karkia, R., Sisu, C., Saravi, S., Kyrou, I., Randeva, H. S., Chatterjee, J., & Karteris, E. (2025). Effects of Asprosin and Role of TLR4 as a Biomarker in Endometrial Cancer. Molecules. https://doi.org/10.3390/molecules30163410
Vancouver
Karkia R, Sisu C, Saravi S, Kyrou I, Randeva HS, Chatterjee J, et al. Effects of Asprosin and Role of TLR4 as a Biomarker in Endometrial Cancer. Molecules. 2025. doi:10.3390/molecules30163410
BibTeX
@article{Karkia2025,
author = {Karkia, Rebecca and Sisu, Cristina and Saravi, Sayeh and Kyrou, Ioannis and Randeva, Harpal S and Chatterjee, Jayanta and Karteris, Emmanouil},
title = {Effects of Asprosin and Role of TLR4 as a Biomarker in Endometrial Cancer},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30163410}
}
EUVIMED